Floatz logo

Adalimumab

Psoriasis

Innovaderm Research Inc.monoclonal_antibodyPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Psoriasis cohort.

Asset / SponsorPhaseRating
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Amgen
Phase 4BBB
Calcipotriene
Hospital Universitario Dr. Jose E. Gonzalez
Phase 4BBB
Tirzepatide
Eli Lilly and Company
Phase 4BBB
cp-690,550
Pfizer
Phase 3BBB
Semaglutide
Hospital Universitario Dr. Jose E. Gonzalez
Phase 4BBB

View all 28 →

Same molecule, other indications

Adalimumab is also rated in:

obstructive sleep apnea syndromeDormant
BB
Indicative ·
69 / 100
View asset →
sciaticaDormant
B
Indicative ·
57 / 100
View asset →
Netherton syndromeDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →